Announcements Trials
Browse Landscape

Phase

Phase 1 102Phase 2 75Phase 1/2 51Phase 3 6Phase NA 5Phase EARLY_PHASE1 3Phase 2/3 3

Status

Completed 4Withdrawn 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 3Thoracic 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 3Breast Neoplasms, Male 2Triple Negative Breast Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Neoplasms 1Depression 1Brain Neoplasms 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 259Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 146Surgical Procedures, Operative 135Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 79Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Vorinostat × Clear all
NCT01720602 2020-01-07

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

University of Washington

Phase NA Completed
15 enrolled 10 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01153672 2019-09-06

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

University of Washington

Phase NA Completed
8 enrolled 10 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00735826 2018-10-12

A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer

Dartmouth-Hitchcock Medical Center

Phase NA Completed
10 enrolled 7 charts
GastrointestinalHead & NeckThoracic

Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms

NCT01342757 2018-01-29

Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma

National Cancer Institute (NCI)

Phase NA Completed
12 enrolled 8 charts
CNS

Brain Neoplasms, Depression, Glioblastoma

NCT01695057 2014-01-28

Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer

University of Southern California

Phase NA Withdrawn
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡